Apr 24, 2017 12:01 pm UTC| Business
MALVERN, Pa., April 24, 2017 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biotechnology company focused on defining new standards of care in medical and aesthetic dermatology, today announced it will...
Apr 24, 2017 12:01 pm UTC| Business
MALVERN, Pa., April 24, 2017 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biotechnology company focused on defining new standards of care in medical and aesthetic dermatology, today announced it will...
Digiliti Money Sets First Quarter 2017 Earnings Call for Thursday, May 11 at 4:30 p.m. EST
Apr 24, 2017 12:01 pm UTC| Business
MINNEAPOLIS, April 24, 2017 -- Digiliti Money (NASDAQ:DGLT), a leading mobile FinTech provider of cloud-based remote deposit capture (RDC) and mobile prepaid card solutions, will hold a conference call on Thursday, May...
Digiliti Money Sets First Quarter 2017 Earnings Call for Thursday, May 11 at 4:30 p.m. EST
Apr 24, 2017 12:01 pm UTC| Business
MINNEAPOLIS, April 24, 2017 -- Digiliti Money (NASDAQ:DGLT), a leading mobile FinTech provider of cloud-based remote deposit capture (RDC) and mobile prepaid card solutions, will hold a conference call on Thursday, May...
Hooper Holmes Selected by Paradigm Health Plans for Biometric Screenings
Apr 24, 2017 12:01 pm UTC| Business
OLATHE, Kan., April 24, 2017 -- Hooper Holmes, Inc. (NYSE MKT:HH), a leading provider of health, wellness and biometric screening services today announced the award of a new service contract with Paradigm Health Plans®...
Hooper Holmes Selected by Paradigm Health Plans for Biometric Screenings
Apr 24, 2017 12:01 pm UTC| Business
OLATHE, Kan., April 24, 2017 -- Hooper Holmes, Inc. (NYSE MKT:HH), a leading provider of health, wellness and biometric screening services today announced the award of a new service contract with Paradigm Health Plans®...
Lipocine Completes Enrollment in the LPCN 1021 Fixed Dose Clinical Trials
Apr 24, 2017 12:00 pm UTC| Business
Top-line data from the studies expected in June 2017 SALT LAKE CITY, April 24, 2017 -- Lipocine Inc. (NASDAQ:LPCN), a specialty pharmaceutical company, today announced the completion of enrollment for both its dosing...
Tariff Tremors: Trump’s Greenland Fight Rattles Global Markets